Alison Fitzgerald Kodjak is a health policy correspondent on NPR's Science Desk.
Her work focuses on the business and politics of health care and how those forces flow through to the general public. Her stories about drug prices, limits on insurance, and changes in Medicare and Medicaid appear on NPR's shows and in the Shots blog.
She joined NPR in September 2015 after a nearly two-decade career in print journalism, where she won several awards—including three George Polk Awards—as an economics, finance, and investigative reporter.
She spent two years at the Center for Public Integrity, leading projects in financial, telecom, and political reporting. Her first project at the Center, "After the Meltdown," was honored with the 2014 Polk Award for business reporting and the Society of Professional Journalists Sigma Delta Chi award.
Her work as both reporter and editor on the foreclosure crisis in Florida, on Warren Buffet's predatory mobile home businesses, and on the telecom industry were honored by several journalism organizations. She was part of the International Consortium of Investigative Journalists team that won the 2015 Polk Award for revealing offshore banking practices.
Prior to joining the Center, Fitzgerald Kodjak spent more than a decade at Bloomberg News, where she wrote about the convergence of politics, government, and economics. She interviewed chairs of the Federal Reserve and traveled the world with two U.S. Treasury secretaries.
And as part of Bloomberg's investigative team, she wrote about the bankruptcy of General Motors Corp. and the 2010 Gulf Oil Spill. She was part of a team at Bloomberg that successfully sued the Federal Reserve to release records of the 2008 bank bailouts, an effort that was honored with the 2009 George Polk Award. Her work on the international food price crisis in 2008 won her the Overseas Press Club's Malcolm Forbes Award.
Fitzgerald Kodjak and co-author Stanley Reed are authors of In Too Deep: BP and the Drilling Race that Took It Down, published in 2011 by John Wiley & Sons.
In January 2019, Fitzgerald Kodjak began her one-year term as the President of the National Press Club in Washington, DC.
She's a graduate of Georgetown University and Northwestern University's Medill School of Journalism.
She raises children and chickens in suburban Maryland.
Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit.
A federal judge has struck down a Medicaid work requirement in Arkansas and Kentucky. This is a major blow to the Trump administration's vision for the health insurance program for low-income people.
Justice Department files notice that it agrees with a federal judge's ruling that the ACA should be thrown out. The administration had previously said it wanted only parts of the law invalidated.
The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.
Democratic Sen. Kamala Harris, who's a candidate for the 2020 presidential election, has endorsed "Medicare for all." But the details of what that means are rather elusive.
A federal judge in Texas issued a ruling Friday declaring the Affordable Care Act unconstitutional, apparently setting the stage for another hearing on the health care law by the U.S. Supreme Court.
The pace of enrollment in Affordable Care Act plans was slower than in past years. About 8.5 million people enrolled in health plans for 2019 through the federal HealthCare.gov.
Ballot initiatives in Utah, Nebraska and Idaho will determine whether to expand Medicaid, after legislators refused to do so. Montanans will vote on whether to keep the state's expansion intact.
The governor of Arizona removed a doctor from the state's Medicaid drug committee and issued an executive order requiring disclosure of financial conflicts in response to a joint investigation by NPR and the Center for Public Integrity Investigation.
The Trump administration on Wednesday releases its final rule on short-term health policies that don't have the same consumer protections as plans governed by the Affordable Care Act.